Maynard Um
-
-
-
-
-
-
-
TD Cowen notes short interest shifts in life science tools stocks
-
-
-
-
-
-
-
Clairity, Myriad Genetics and MagView launch integrated breast cancer risk platform
-
-
-
-
-
-
-
Myriad Genetics (MYGN) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY25 Guidance
-
-
-
-
-
-
-
Myriad Genetics (MYGN) PT Lowered to $20 at Scotiabank
-
-
-
-
-
-
-
Craig-Hallum Starts Myriad Genetics (MYGN) at Buy, 'We would be buying MYGN'
-
-
-
-
-
-
-
Leerink Partners Downgrades Myriad Genetics (MYGN) to Market Perform
-
-
-
-
-
-
-
Myriad Genetics (MYGN) and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record Integration
-
448,492 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

